Tetra Bio-Pharma Inc.
TBP
Rangering i aksjer
#35465
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Aksjekurs
$0.01851783
Sist synkronisert: 2023-05-23
Markedsverdi
$3.71M
Endring (1 dag)
-0.04%
Endring (1 år)
1,443.15%
Land
CA
Handel Tetra Bio-Pharma Inc. (TBP)
Kategori
Healthcare
Markedsverdi av Tetra Bio-Pharma Inc.(TBP)
Markedsverdi: $3.71M
Per October 2026 har Tetra Bio-Pharma Inc. en markedsverdi på $3.71M. Dette gjør Tetra Bio-Pharma Inc. til det 35465th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Tetra Bio-Pharma Inc. fra 2011 til 2026
TBP sammenlignet med topp 5 mest populære stocks
| Pris på TBP | Eiendel B | Markedsverdi for B | Resultater | |
|---|---|---|---|---|
$26,595.82
$233.14K
|
$5.167T | +2,216,318,231.04% | ||
|
$25,812.10
$233.14K
|
$5.015T | +2,151,008,403.89% | ||
|
$21,146.79
$233.14K
|
$4.108T | +1,762,232,661.36% | ||
|
$20,083.90
$233.14K
|
$3.902T | +1,673,658,479.36% | ||
|
$13,843.18
$233.14K
|
$2.689T | +1,153,598,619.27% |
